ASCIA News
-
New ASCIA penicillin allergy e-training course
3 December 2018: Penicillin allergy is the most common drug allergy and is self-reported in up to 18 percent of hospitalised patients. However, most (up to 90%) of patients with a penicillin allergy label are found not to be allergic on further assessment. Importantly, in th... -
ASCIA appoints new Project Officer to focus on ASCIA Education Project
30 November 2018: It is a pleasure to announce that Nadene Dorling has been appointed as a new ASCIA Project Officer. Nadene has extensive experience in health education communications and organising conferences, medical education and patient education programs. Her skills a... -
Updated ASCIA cow’s milk (dairy) allergy patient information
19 November 2018: Cow’s milk (dairy) allergy affects around 2% (1 in 50) babies In Australia and New Zealand. In recent years deaths from severe allergic reactions (anaphylaxis) to cow’s milk have occurred in allergic babies and children. ASCIA patient information has theref... -
New ASCIA Fast Facts on asthma, autoimmunity and eczema
9 November 2018: Asthma and allergy, autoimmune diseases and eczema (atopic dermatitis) are the latest topics to be added to ASCIA Fast Facts. A total of 12 ASCIA Fast Facts topics are now available on the ASCIA website www.allergy.org.au/patients/fast-facts ASCIA Fast Facts... -
New translations of ASCIA anaphylaxis information
5 November 2018: Translations of ASCIA anaphylaxis information into 21 languages have been funded by an educational grant from the Sydney Children's Hospitals Network (SCHN). They are available open access on the ASCIA website www.allergy.org.au/hp/anaphylaxis#ta5 The follow... -
New ASCIA Fast Facts information
2 November 2018: ASCIA Fast Facts have been developed to provide concise, easy to understand and reliable information on allergy and other immune diseases for patients, carers and the community. The first 12 topics are available on the ASCIA website www.allergy.org.au/patien... -
New MBS item numbers for allergy testing – effective 1 November 2018
31 October 2018: New Medicare Benefits Schedule (MBS) item numbers for allergy testing are effective as of 1 November 2018. The following are responses to questions that ASCIA has recently received about the new MBS item numbers: MBS item numbers 12000 and 12003 can be co-cl... -
AusPollen PreSeason Questionnaire
2 October 2018: Local AusPollen Apps provide daily levels of pollen in the air, which can help if you have hay fever (allergic rhinitis) or if your asthma is made worse by allergens in the air. To help the AusPollen team evaluate usefulness of the Apps and how they can impro...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information.Verify here.